Sven Weiler

536 total citations
10 papers, 343 citations indexed

About

Sven Weiler is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Sven Weiler has authored 10 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Sven Weiler's work include Peptidase Inhibition and Analysis (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Sven Weiler is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Sven Weiler collaborates with scholars based in United States, Switzerland and Germany. Sven Weiler's co-authors include David A. Vosburg, Erik J. Sorensen, Christopher D. Vanderwal, Richard R. Schmidt, Christian Beerli, Christian Bergsdorf, Honnappa Srinivas, Anna Schubart, Andreas Billich and Berndt Oberhauser and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Sven Weiler

10 papers receiving 332 citations

Peers

Countries citing papers authored by Sven Weiler

Since Specialization

Citations

This map shows the geographic impact of Sven Weiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Weiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Weiler more than expected).

Fields of papers citing papers by Sven Weiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Weiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Weiler. The network helps show where Sven Weiler may publish in the future.

Co-authorship network of co-authors of Sven Weiler

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Weiler. A scholar is included among the top collaborators of Sven Weiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Weiler. Sven Weiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Discovery of a novel 2-aminopyrazine-3-carboxamide as a potent and selective inhibitor of Activin Receptor-Like Kinase-2 (ALK2) for the treatment of fibrodysplasia ossificans progressiva 2022 ·Bioorganic & Medicinal Chemistry Letters ·Thomas Ullrich, Luca Arista, Sven Weiler, (unknown), (unknown), Nikolaus Stiefl, (unknown), Ina Krämer, Sabine Guth	5
2	Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis 2014 ·Journal of Medicinal Chemistry ·Sven Weiler, (unknown), Christian Beerli, Christian Bergsdorf, Anna Schubart, Honnappa Srinivas, Berndt Oberhauser, Andreas Billich	62
3	Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists) 2010 ·Bioorganic & Medicinal Chemistry Letters ·Marc Gerspacher, Eva Altmann, (unknown), Thomas Buhl, (unknown), R. Gamse, (unknown), Michaela Kneissel, (unknown), Martin Missbach, Alfred Schmidt, Klaus Seuwen, Sven Weiler, Leo Widler	9
4	Concise stereocontrolled routes to fumagillol, fumagillin, and TNP‐470 2003 ·Chirality ·David A. Vosburg, Sven Weiler, Erik J. Sorensen	21
5	An Enantioselective Synthesis of FR182877 Provides a Chemical Rationalization of Its Structure and Affords Multigram Quantities of Its Direct Precursor 2003 ·Journal of the American Chemical Society ·Christopher D. Vanderwal, David A. Vosburg, Sven Weiler, Erik J. Sorensen	113
6	Eine kurze Synthese von Fumagillol 1999 ·Angewandte Chemie ·David A. Vosburg, Sven Weiler, Erik J. Sorensen	9
7	A Concise Synthesis of Fumagillol 1999 ·Angewandte Chemie International Edition ·David A. Vosburg, Sven Weiler, Erik J. Sorensen	33
8	Postulated Biogenesis of WS9885B and Progress toward an Enantioselective Synthesis 1999 ·Organic Letters ·Christopher D. Vanderwal, David A. Vosburg, Sven Weiler, Erik J. Sorensen	38
9	A versatile strategy for the synthesis of complex type N-Glycans: Synthesis of diantennary and bisected diantennary oligosaccharides 1998 ·Tetrahedron Letters ·Sven Weiler, Richard R. Schmidt	37
10	Silyl Group Migration in 1-O-Silyl Protected Sugars-Convenient Synthesis of 2-O-Unprotected Sugars 1996 ·Journal of Carbohydrate Chemistry ·José M. Lassaletta, (unknown), Sven Weiler, Richard R. Schmidt	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact